In context
Oligopeptide-1 appears in topical growth-factor product research. The cited pilot study compared a recombinant epidermal-growth-factor serum with a human-derived growth-factor product. [1]
At a glance
- Type
- Topical cosmetic ingredient
- Regulatory context
- The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.
- Evidence
- Ingredient naming and source material matter. Results from these particular formulations do not establish that every product labelled oligopeptide-1 is equivalent.
How to interpret this evidence
Ingredient naming and source material matter. Results from these particular formulations do not establish that every product labelled oligopeptide-1 is equivalent. [1]
Safety and clinical context
Topical cosmetic research does not support injection or other systemic use. Safety and tolerability depend on the complete formulation and the person using it.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Primary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.